tiprankstipranks
Mochida Pharmaceutical Co., Ltd. (DE:MFY)
FRANKFURT:MFY
Germany Market
Holding DE:MFY?
Track your performance easily

Mochida Pharmaceutical Co., Ltd. (MFY) Financial Statements

0 Followers

Mochida Pharmaceutical Co., Ltd. Financial Overview

Mochida Pharmaceutical Co., Ltd.'s market cap is currently ―. The company's EPS TTM is €0.781; its P/E ratio is ―; and it has a dividend yield of 2.46%. Mochida Pharmaceutical Co., Ltd. is scheduled to report earnings on February 7, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 28.19B-$ 27.69B$ 25.36B$ 30.80B
Gross Profit$ 15.74B-$ 15.26B$ 12.72B$ 17.90B
EBIT$ 5.08B-$ 4.26B$ 1.35B$ 6.91B
EBITDA$ 5.08B-$ 4.26B$ 1.35B$ 6.91B
Net Income Common Stockholders$ 4.16B-$ 3.15B$ 389.00M$ 5.26B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 59.65B$ ―$ 62.90B$ 61.91B$ 61.20B
Total Assets$ 160.22B-$ 162.35B$ 163.14B$ 164.99B
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 30.27B-$ 32.30B$ 34.50B$ 35.45B
Stockholders Equity$ 129.95B$ ―$ 130.05B$ 128.64B$ 129.54B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Mochida Pharmaceutical Co., Ltd. Earnings and Revenue History

Mochida Pharmaceutical Co., Ltd. Debt to Assets

Mochida Pharmaceutical Co., Ltd. Cash Flow

Mochida Pharmaceutical Co., Ltd. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis